Method and composition related to combination therapy for addiction
US11207322B2 · kind B2 · utility
1Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2018 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | Apr 29, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain embodiments are directed to methods of treating or preventing an addictive behavior in a subject by administering to the subject an effective amount of a 5-HT2C receptor agonist in combination with a DA D3/D4 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.